Anesthetic management of pulmonary endarterectomy in a patient with suprasystemic pulmonary pressure: a case report
DOI:
https://doi.org/10.18203/2320-6012.ijrms20202286Keywords:
Anesthetic management, Chronic thromboembolic pulmonary hypertension, Pulmonary endarterectomy, Reperfusion pulmonary edemaAbstract
Pulmonary endarterectomy (PEA) is a potentially curative procedure for chronic thromboembolic pulmonary hypertension. A 34-year Indian male presented with supra-systemic pulmonary pressure was taken for PEA after achievable optimization. A successful PEA was performed with the help of total cardiac arrest. Patient developed reperfusion pulmonary edema post operatively, which was managed medically. The problems encountered by anesthesiologists in this case were preoperative pulmonary hypertension with chronic hypoxia and postoperative management of reperfusion pulmonary edema.
Metrics
References
Banks DA, Pretorius GV, Kerr KM, Manecke GR. Pulmonary endarterectomy: part I. Pathophysiology, clinical manifestations, and diagnostic evaluation of chronic thromboembolic pulmonary hypertension. In Seminars in cardiothoracic and vascular anesthesia 2014;18(4):319-30.
Lewczuk J, Piszko P, Jagas J, Porada A, Sobkowicz B, Wrabec K, et al. Prognostic factors in medically treated patients with chronic pulmonary embolism. Chest. 2001;119(3):818-23.
Tempe DK. Perioperative management of pulmonary hypertension. Ann Card Anaesth. 2010;13(2):89-91.
McNeil K, Dunning J, Morrell N. The pulmonary physician in critical care• 13: The pulmonary circulation and right ventricular failure in the ITU. Thorax. 2003;58(2):157.
Manecke Jr GR, Kotzur A, Atkins G, Fedullo PF, Auger WR, Kapelanski DP, Jamieson SW. Massive pulmonary hemorrhage after pulmonary thromboendarterectomy. Anesth Analg. 2004;99(3):672-5.
Makowski CT, Rissmiller RW, Bullington WM. Riociguat: a novel new drug for treatment of pulmonary hypertension. Pharmacotherapy: J Human Pharmacol Drug Ther. 2015;35(5):502-19.